Peroxiredoxin 3 regulates breast cancer progression via ERK-mediated MMP-1 expression.

Authors:
Chua PJ; Ow SH; Ng CT; Huang WH; Low JT and 3 more

Journal:
Cancer Cell Int

Publication Year: 2024

DOI:
10.1186/s12935-024-03248-x

PMCID:
PMC10845805

PMID:
38321552

Journal Information

Full Title: Cancer Cell Int

Abbreviation: Cancer Cell Int

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateEthics approval for the use of the Breast Cancer Tissue Microarrays was obtained from the Singhealth Centralized Institutional Review Board (Protocol CIRB 2011/433/F). Consent for publicationAll authors have read the final manuscript and agreed to publish it. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This research was funded by National Medical Research Council of Singapore (NMRC/CIRG/1370/2013) and the Kwan In Thong Hood Cho Temple Professorship to B.H.B., as well as the National Science and Technology Council, Taiwan (NSTC 110-2314-B-194-002-MY3), and the Center for Innovative Research on Aging Society (CIRAS) from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by Ministry of Education (MOE) in Taiwan to M.W.Y.C."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025